InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Managed Funds
  5. Goldman Sachs Global Health & Biotech Wholesale - Managed fund profile

Goldman Sachs Global Health & Biotech Wholesale - Managed Fund (Closed)

Fund Objective
To achieve long-term capital growth by investing in healthcare: biotechnology and related companies globally. In doing so, the Fund aims to outperform the S&P GSSI Health Care Index in A$ over rolling three-year periods. The Fund invests in an underlying pooled fund, the Goldman Sachs JBWere Global Health & Biotech Pooled Fund.
Fund Strategy
The Fund invests in securities of companies across the major sub-sectors of the healthcare and biotech industry. Some representation is typically maintained in each major sub-sector of the healthcare and/or biotech industry. It can invest up to 25% of assets in companies in emerging markets. The Fund invests at least 80% of assets in equity securities and can invest up to 20% of assets in cash. It holds generally 40-70 securities in the portfolio.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.
grow your money
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns.
Free Fees Report
investing
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers.
Free investor guide
Grow your money, not your fees
It's fees rather than returns that make the biggest difference to your investment's compounding returns. Free Fees Report
Investing made simple
Our professionally-tailored investment portfolios consistently beat most of our peers. Free investor guide

Fees Comparison

{{ fund.mer | number:2 }}
% p.a.
{{ fund.name }}
{{ modelPortfolio.mer * 100 | number:2 }}
% p.a.
{{ modelPortfolio.name }}
{{ fund.benchmark.peers.mer * 100 | number:2 }}
% p.a.
Average of peers ({{ fund.benchmark.peers.peerCount }})
NOTE: Fee data has been provided by Morningstar, it may not include all costs being charged on your investment such as platform and adviser fees. You should check your fund manager or adviser statements to find out the exact fees you are being charged. Peers are funds that use the same benchmark in the Morningstar database.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return 3.2% 5.53% 10.74% 8.81% 4.41% -4% 2.55% -%
Growth return 3.2% 5.53% 10.74% 8.81% 4.41% -4% 2.55% -%
Income return 0% 0% 0% 0% 0% 0% 0% -%
Market index (MSCI World Ex Australia NR AUD)
Total return 3.02% 14.06% 20.11% 28.72% 15.87% 14.43% -% 13.43%
As at 31 Mar 2010. Returns for periods greater than 1 year are annualised. All figures are percentages.

Asset Allocation

Goldman Sachs Global Health & Biotech Wholesale
International Equities
98.41%
Cash
1.59%
Australian Equities
0%
Property
0%
Fixed Interest
0%
Alternatives
0%
Average Allocation of Peers
International Equities
92.05%
Cash
3.01%
Australian Equities
3.12%
Property
1.80%
Fixed Interest
-0.04%
Alternatives
0.06%

General Information

Fund Details
Type Description
Goldman Sachs Global Health & Biotech Wholesale (Wholesale)
Closed
Goldman Sachs Australia Managed Fds Ltd.
JBW0111AU
Equity World Other
Not Rated
Investment Fund
1 Nov 2000
$12.19 million (as at 31 Mar 2010)
$0.8908 (as at 21 Apr 2010)
$0.8871 (as at 21 Apr 2010)
Finalised
Offer information
Type Description
Indirect Cost Ratio (ICR) 1.60% (as at 30 Jun 2009)
Minimum initial investment $50,000
Minimum additional investments $1,000.00

Top 10 holdings (as at 31 Mar 2010)

Holding (as at 31 Mar 2010) Type % of Portfolio
Pfizer Inc. Stock 4.82%
Login now to view the complete list of holdings.

FAQs about the Goldman Sachs Global Health & Biotech Wholesale

The objective of the Goldman Sachs Global Health & Biotech Wholesale managed fund is To achieve long-term capital growth by investing in healthcare: biotechnology and related companies globally. In doing so, the Fund aims to outperform the S&P GSSI Health Care Index in A$ over rolling three-year periods. The Fund invests in an underlying pooled fund, the Goldman Sachs JBWere Global Health & Biotech Pooled Fund.

The strategy of the Goldman Sachs Global Health & Biotech Wholesale managed fund is The Fund invests in securities of companies across the major sub-sectors of the healthcare and biotech industry. Some representation is typically maintained in each major sub-sector of the healthcare and/or biotech industry. It can invest up to 25% of assets in companies in emerging markets. The Fund invests at least 80% of assets in equity securities and can invest up to 20% of assets in cash. It holds generally 40-70 securities in the portfolio.

The APIR code of the Goldman Sachs Global Health & Biotech Wholesale managed fund is JBW0111AU.

Goldman Sachs Global Health & Biotech Wholesale’s total return last month was 3.2%. This was made up of a growth return of 3.2% and an income return of 0%. These returns were calculated as at 31 Mar 2010.

Goldman Sachs Global Health & Biotech Wholesale’s total return for the last three months was 5.53%. This was made up of a growth return of 5.53% and an income return of 0%%. These returns were calculated as at 31 Mar 2010.

Goldman Sachs Global Health & Biotech Wholesale’s one-year total return is 8.81%. This was made up of a growth return of 8.81% and an income return of 0%. These returns were calculated as at 31 Mar 2010.

Goldman Sachs Global Health & Biotech Wholesale’s one-year total return is -4%. This was made up of a growth return of -4% and an income return of 0%. These returns were calculated as at 31 Mar 2010.

The asset allocation of the Goldman Sachs Global Health & Biotech Wholesale managed fund is :

International Equities
98.41%
Cash
1.59%
Australian Equities
0%
Property
0%
Fixed Interest
0%
Alternatives
0%

The Responsible Entity for the Goldman Sachs Global Health & Biotech Wholesale managed fund is Goldman Sachs Australia Managed Fds Ltd..

The Goldman Sachs Global Health & Biotech Wholesale managed fund belongs to the Equity World Other sector/asset class.

As at 31 Mar 2010, the size of the Goldman Sachs Global Health & Biotech Wholesale managed fund was $12.19 million.

The Goldman Sachs Global Health & Biotech Wholesale managed fund has an inception date of 1 Nov 2000.

The current entry price of the Goldman Sachs Global Health & Biotech Wholesale managed fund is $0.8908 per unit and the current exit price is $0.8871 per unit (as at 21 Apr 2010).

The current exit price of the Goldman Sachs Global Health & Biotech Wholesale managed fund is $0.8871 per unit and the current entry price is $0.8908 per unit (as at 21 Apr 2010).

The minimum initial investment amount for the Goldman Sachs Global Health & Biotech Wholesale managed fund is $50,000. Minimum additional investment is $1000.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.